Skip to main content
SXI logo

SXI · Standex International Corp · Debt

Track SXI — free
Market Cap
$2.82B
Shares
12.10M
Volume · Nov 18 105.85K Avg daily vol (3M) 140.89K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 12,709,000 10-Q filed 2026-10-30
Long-term debt, including current maturities 2026-09-30 USD 518,058,000 10-Q filed 2026-10-30
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Noncurrent debt carrying amount
USD 518,058,000
Noncurrent operating lease liabilities 2026-09-30 USD 32,769,000 10-Q filed 2026-10-30
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

Term Loan

TermLoan · Standex International Corporation

Reference: Term Loan

Past stated maturity
Original principal
USD 250,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 27, 2025

Last reported interest terms: Standex will pay a variable rate of interest. As time goes on, the variable rate charge will increase. Reported 2024-10-31 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-10-28 Original principal USD 250,000,000 Exact source document Parent 8-K filing · 2024-10-31
    On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
    Issuer evidence: On October 28, 2024 (the “Closing Date”), Standex International Corporation, a Delaware corporation (“Standex”), acquired Amran, LLC, a Texas limited liability company (“Amran”), pursuant to a Securities Purchase Agreement dated as of the Closing Date (the “Amran Purchase Agreement”) by and among Standex, Amran, the parties listed as “Owners” therein, Bolt Founders, Inc. (“Bolt”) and the Seller Representative (as defined therein) (the “Amran Transaction”). Pursuant to the Amran Purchase Agreement, on the Closing Date, Standex acquired 100% of the outstanding membership interests of Amran from Bolt, in consideration for an aggregate of $180,600,000 (the “Amran Consideration”). The Amran Consideration consisted of $153,510,000 paid in cash in consideration for 85% of the outstanding membership interests of Amran and 152,299 shares of Standex common stock (the “Amran Issued Securities”) for the remaining 15% of the outstanding membership interests of Amran, reflecting the equivalent of $27,090,000, divided by $177.87 (the “Closing Price”), being the volume weighted average price of Standex’s common stock measured over a 30-day trading period preceding the Closing Date. The Amran Issued Securities were not registered under the Securities Act of 1933, as amended (the “Securities Act”). Standex issued the Amran Issued Securities to Bolt, an “accredited investor” as defined in Regulation D promulgated under the Securities Act, in a transaction exempt from registration under the Securities Act pursuant to Section 4(a)(2) of the Securities Act. The Amran Purchase Agreement contains certain restrictions on the sale of the Amran Issued Securities during the first three years after the Closing Date.
    Supporting evidence: Under the terms of the Term Loan Credit Agreement, Standex will pay a variable rate of interest. As time goes on, the variable rate charge will increase. The Term Loan may be in the form of either Alternate Base Rate or Term SOFR loans. The rate of interest on Alternate Base Rate loans shall be the higher of (i) the Federal Funds rate plus ½ of 1%, (ii) the “prime rate” announced by Citizens Bank, N. A. or (iii) the daily SOFR Rate on such day plus 1%, plus an additional amount based upon the time period. The rate of interest on SOFR Rate loans shall be the Term SOFR Reference Rate plus 0.1% rate which corresponds to a one month interest period, plus an additional amount based upon the time period.
    Supporting evidence: The Term Loan matures on October 27, 2025, and contains customary representations, warranties and restrictive covenants, each of which are substantially similar to such representations, warranties and covenants contained in the Revolving Credit Agreement (as defined below).
    Supporting evidence: On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
    Supporting evidence: On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
Key facts CIK 310354 CUSIP 854231107 13F (30d) 333 filings 294 filers Visit website Investor relations